Lorcaserin in the Treatment of Cocaine Use Disorder
Public ClinicalTrials.gov record NCT03007394. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to evaluate the efficacy and safety of lorcaserin in the treatment of cocaine use disorder.
Study identification
- NCT ID
- NCT03007394
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 272 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 18, 2017
- Primary completion
- Nov 30, 2019
- Completion
- Nov 30, 2019
- Last update posted
- Aug 4, 2020
2017 – 2019
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pacific Treatment and Research Center | La Jolla | California | 92307 | — |
| Matrix Institute on Addictions | Los Angeles | California | 90016 | — |
| Pharmacology Research Institute | Newport Beach | California | 92660-2452 | — |
| George Washington University | Washington D.C. | District of Columbia | 20052 | — |
| Meridien Research | Lakeland | Florida | 33805 | — |
| Behavioral Clinical Research, Inc. | North Miami | Florida | 33161 | — |
| Boston University School of Medicine | Boston | Massachusetts | 02118-2391 | — |
| Altea Research Institute | Las Vegas | Nevada | 89102 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| Neuro-Behavioral Clinical Research Inc. | Canton | Ohio | 44718 | — |
| University of Cincinnati | Cincinnati | Ohio | 45229 | — |
| CODA, Inc. | Portland | Oregon | 97214 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03007394, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2020 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03007394 live on ClinicalTrials.gov.